Anaphylaxis: Clinical patterns, mediator release, and severity

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 5, 2013, Pages

  Brown, Simon G A ^a,b,c,d   Stone, Shelley F ^a,b   Fatovich, Daniel M ^a,b,c   Burrows, Sally A ^b   Holdgate, Anna ^e   Celenza, Antonio ^b,f   Coulson, Adam ^g   Hartnett, Leanne ^d,h   Nagree, Yusuf ^d,i   Cotterell, Claire ^a   Isbister, Geoffrey K ^j,k  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d FREMANTLE HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^g Bunbury Regional Hospital   (Australia)

^h Rockingham General Hospital   (Australia)

ⁱ C/ Armadale Kelmscott Memorial Hospital Emergency Department   (Australia)

^j CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^k UNIVERSITY OF NEWCASTLE   (Australia)

more..

Author keywords

Anaphylaxis; biphasic anaphylaxis; emergency department; histamine; interleukin; mast cell tryptase; platelet activating factor; platelet activating factor acetyl hydrolase; soluble tumor necrosis factor receptor I

Indexed keywords

ACETYL HYDROLASE; ADRENALIN; ANAPHYLATOXIN; ANAPHYLATOXIN C3A; ANAPHYLATOXIN C4A; COMPLEMENT COMPONENT C5A; HISTAMINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; THROMBOCYTE ACTIVATING FACTOR; TRYPTASE; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPOTENSION; HYPOXEMIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MAST CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

EID: 84887025894     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.06.015     Document Type: Article

References (31)

1. F.E. Simons, L.R. Ardusso, M.B. Bilò, Y.M. El-Gamal, D.K. Ledford, and J. Ring World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis World Allergy Organ J 4 2011 13 37
2. H.A. Sampson, A. Munoz-Furlong, R.L. Campbell, N.F. Adkinson, S.A. Bock, and A. Branum Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium J Allergy Clin Immunol 117 2006 391 397
3. S.G. Brown Clinical features and severity grading of anaphylaxis J Allergy Clin Immunol 114 2004 371 376
4. R.S. Pumphrey Lessons for management of anaphylaxis from a study of fatal reactions Clin Exp Allergy 30 2000 1144 1150
5. Y. Ogawa, and J.A. Grant Mediators of anaphylaxis Immunol Allergy Clin North Am 27 2007 249 260 vii
6. S.G. Brown, R.J. Mullins, and M.S. Gold Anaphylaxis: diagnosis and management Med J Aust 185 2006 283 289
7. S.F. Stone, C. Cotterell, G.K. Isbister, A. Holdgate, and S.G. Brown Elevated serum cytokines during human anaphylaxis: identification of potential mediators of acute allergic reactions J Allergy Clin Immunol 124 2009 786 792.e4
8. P. Vadas, M. Gold, B. Perelman, G.M. Liss, G. Lack, and T. Blyth Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis N Engl J Med 358 2008 28 35
9. W. Rogers Regression standard errors in clustered samples Stata Tech Bull 3 1994 19 23
10. S.G. Brown, and S.F. Stone Laboratory diagnosis of acute anaphylaxis Clin Exp Allergy 41 2011 1660 1662
11. S.G. Brown, K.E. Blackman, and R.J. Heddle Can serum mast cell tryptase help diagnose anaphylaxis? Emerg Med Australas 16 2004 120 124
12. A. Helmy, C.A. Antoniades, M.R. Guilfoyle, K.L. Carpenter, and P.J. Hutchinson Principal component analysis of the cytokine and chemokine response to human traumatic brain injury PLoS One 7 2012 e39677
13. F. Yao, J. Coquery, and K.A. Lê Cao Independent principal component analysis for biologically meaningful dimension reduction of large biological data sets BMC Bioinformatics 13 2012 24
14. I. Jollife Principal Component Analysis 2nd ed. 2002 Springer New York, NY
15. S.C. Braganza, J.P. Acworth, D.R. McKinnon, J.E. Peake, and A.F. Brown Paediatric emergency department anaphylaxis: different patterns from adults Arch Dis Child 91 2006 159 163
16. F. Huang, K. Chawla, K.M. Järvinen, and A. Nowak-Wȩgrzyn Anaphylaxis in a New York City pediatric emergency department: triggers, treatments, and outcomes J Allergy Clin Immunol 129 2012 162 168 e1-3
17. P. Vadas, B. Perelman, and G. Liss Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis J Allergy Clin Immunol 131 2013 144 149
18. W.K. Liew, E. Williamson, and M.L. Tang Anaphylaxis fatalities and admissions in Australia J Allergy Clin Immunol 123 2009 434 442
19. S.A. Bock, A. Muñoz-Furlong, and H.A. Sampson Fatalities due to anaphylactic reactions to foods J Allergy Clin Immunol 107 2001 191 193
20. J.W. Tole, and P. Lieberman Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations Immunol Allergy Clin North Am 27 2007 309 326 viii
21. A. Muraro, G. Roberts, A. Clark, P.A. Eigenmann, S. Halken, and G. Lack The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology Allergy 62 2007 857 871
22. P.W. van der Linden, C.E. Hack, J. Poortman, Y.C. Vivie-Kipp, A. Struyvenberg, and J.K. van der Zwan Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation J Allergy Clin Immunol 90 1992 110 118
23. P.W. van der Linden, C.E. Hack, J.A. Kerckhaert, A. Struyvenberg, and J.C. van der Zwan Preliminary report: complement activation in wasp-sting anaphylaxis Lancet 336 1990 904 906
24. E. Ono, M. Taniguchi, H. Mita, Y. Fukutomi, N. Higashi, and E. Miyazaki Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis Clin Exp Allergy 39 2009 72 80
25. M.M. Marc, P. Korosec, M. Kosnik, I. Kern, M. Flezar, and S. Suskovic Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma Am J Respir Cell Mol Biol 31 2004 216 219
26. U. del Balzo, M.J. Polley, and R. Levi Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects J Pharmacol Exp Ther 246 1988 911 916
27. G. Pidde-Queiroz, M.F. de Furtado, C.F. Filgueiras, L.A. Pessoa, M. Spadafora-Ferreira, and C.W. van den Berg Human complement activation and anaphylatoxins generation induced by snake venom toxins from Bothrops genus Mol Immunol 47 2010 2537 2544
28. M. Khodoun, R. Strait, T. Orekov, S. Hogan, H. Karasuyama, and D.R. Herbert Peanuts can contribute to anaphylactic shock by activating complement J Allergy Clin Immunol 123 2009 342 351
29. Y. Fukuoka, H.-Z. Xia, L.B. Sanchez-Muñoz, A.L. Dellinger, L. Escribano, and L.B. Schwartz Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5 J Immunol 180 2008 6307 6316
30. C.M. Williams, and S.J. Galli The diverse potential effector and immunoregulatory roles of mast cells in allergic disease J Allergy Clin Immunol 105 2000 847 859
31. F. Jönsson, D.A. Mancardi, Y. Kita, H. Karasuyama, B. Iannascoli, and N. Van Rooijen Mouse and human neutrophils induce anaphylaxis J Clin Invest 121 2011 1484 1496